首页/数据集/Investigation of the transcriptional effects of Bevacizumab treatment in two epithelial ovarian cancer PDX models

Investigation of the transcriptional effects of Bevacizumab treatment in two epithelial ovarian cancer PDX models

ChEBI2024-12-05 更新2026-07-12 收录

卵巢癌治疗

转录组药物响应

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MTAB-14679 数据链接链接失效反馈

官方服务：

资源简介：

Investigation of the transcriptional effects of Bevacizumab treatment in two epithelial ovarian cancer PDX models

应用场景：

创建时间：

2024-12-05

相关数据集

Fig8

卵巢癌治疗

免疫细胞疗法

Schematic illustration of eNK-EXO enhance the anti-tumor effects against ovarian cancer by delivering chemotherapeutic drugs and reactivating NK cell functions

NIAID Data Ecosystem80

Complete list of synlet interactions addressed by novel drug combinations.

合成致死药物

卵巢癌治疗

The full list of addressed synlet interactions as well as the respective novel proposed drug combinations are given in the S1 Table. Synlet interactions are sorted in descending order based on the sum

NIAID Data Ecosystem50

Table_1_A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy.DOCX

卵巢癌治疗

剂量递增研究

Background: Epithelial ovarian cancer (EOC) is the leading cause of gynecological cancer-related deaths worldwide. Preclinical studies found that copper-lowering agents could re-sensitize platinum-res

NIAID Data Ecosystem30

PIM2 Kinase Is Induced by Cisplatin in Ovarian Cancer Cells and Limits Drug Efficacy

卵巢癌治疗

激酶调控

Platinum-based chemotherapy is widely used to treat various cancers, but many patients ultimately relapse due to drug resistance. We employed phosphoproteomic analysis and functional assays of the res

NIAID Data Ecosystem60

Suppression of adaptive responses to targeted cancer therapy by transcriptional repression [RNA-seq]. Homo sapiens

肿瘤耐药机制

转录组药物响应

Large-scale genomic profiling efforts have facilitated the characterization of molecular alterations in cancers and aided the development of targeted kinase inhibitors for a wide array of cancer types

NIAID Data Ecosystem50